However, some populations are at risk of hyperkalemia, including those living with kidney disease, diabetes mellitus, or heart disease, and those taking renin–angiotensin–aldosterone system inhibitors (RAASi) [27,28,29]. Here, REN is linked to diabetes mellitus.